Company / Return on Assets (ROA)
Mirum Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-2.8%
FY2025
5-year range
-35.0% / -2.8%
FY2021-FY2025
Trend
+78.9%
vs FY2024
Sector context
#67 of 213
Health Care
What the data says
At -2.8%, Mirum Pharmaceuticals, Inc.'s return on assets (roa) ranks #67 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -42.9% in FY2020 to -2.8% in FY2025.
Based on SEC 10-K filings.
-2.8% in FY2025 with a 5-year CAGR of +40.1%.
Improved from -25.3% to -2.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +21.0pp
- 5-Year Change
- +40.1pp
- 10-Year Change
- -
Sector benchmark
#67 of 213 in Health CareTop 31% of 213This company -2.8% Sector average -24.2%
▼
+88.5% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 78.9% year-over-year.
- Currently 21.4pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2.8% | +78.9% |
| FY2024 | -13.1% | +48.1% |
| FY2023 | -25.3% | -6.2% |
| FY2022 | -23.8% | +32.1% |
| FY2021 | -35.0% | +18.2% |
| FY2020 | -42.9% | -19.7% |
| FY2019 | -35.8% | -7.3% |
| FY2018 | -33.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026